Gagnon Securities LLC Acquires New Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Gagnon Securities LLC bought a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,168 shares of the biopharmaceutical company’s stock, valued at approximately $272,000. Several other hedge […]

Related Keywords

,Piper Sandler ,Merdad Parsey ,Gilead Sciences Stock Down ,Quarter For Gilead Sciences ,Gilead Sciences ,Hanseatic Management Services Inc ,Gagnon Securities ,Barclays ,Gilead Sciences Inc ,Exchange Commission ,Elevate Inc ,Nasdaq ,Securities Exchange Commission ,Gilead Sciences Announces Dividend ,Wells Fargo Company ,News Ratings For Gilead Sciences Daily ,Get Rating ,Wealth Partners ,Management Services ,Duncker Streett ,Sciences Stock Down ,Visit Holdingschannel ,Gilead Sciences Daily ,Nasdaq Gild ,Gild ,Medical ,37555810 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,